Bio/Pharmaceutical Outsourcing Report, September 2026
Summary
The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.Scope
This report gives an important monthly update on the pharmaceutical outsourcing industry, based on analysis from the analyst's experts and our databases covering deals, companies, drugs, financials, news, clinical trials, and more. This report is required reading for:- CMO executives and strategic decision-makers: to improve understanding of the CMO industry and provide a critical input for strategic planning efforts.
- Sourcing and procurement executives in bio/pharmaceutical companies: to improve understanding of crucial components of the supply base that will provide insights for supplier selection and management.
- Investors, advisors, and consultants: they can gain a deeper understanding of the CMO market and important insights for identifying potential investment targets.
Reasons to Buy
- Understand current trends and equip yourself with forward-thinking strategies to navigate challenges and capitalise on emerging trends driving the pharmaceutical manufacturing industry. Use our radar to identify developments and innovations with high impact.
- Discover the latest opportunities and threats in the contract manufacturing industry, based on clinical trials and regulatory decisions.
- Learn about the past quarter’s M&A and financing deals in the manufacturing space.
- Identify the latest contract service agreements.
- Develop your competitor or market intelligence by reading about inspection outcomes and facility investments.
- Stay ahead of disruption with updates on supply chain obstacles and new regulations.
Table of Contents
1 Industry Trends
2 Industry Analysis
3 Value Chain
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 4basebio Plc
- A1 Biochem Labs India Private Limited
- AbClon Inc
- ABL Diagnostics
- ABIONYX Pharma SA
- Acadia Pharmaceuticals Inc
- ACS Dobfar
- Alcami Corp
- ALK-Abello Ltd
- Almac Group Ltd
- American Type Culture Collection
- Amylyx Pharmaceuticals Inc
- Anaquant SAS
- Ardian Holding
- AstraZeneca
- Astrea Pharma
- AtomVie Global Radiopharma Inc
- Aurobindo Pharma Limited
- Axiom Biosciences
- Bachem Americas Inc
- Bayer HealthCare Pharmaceuticals Inc
- BC Partners LLP
- BeiGene USA Inc
- Besins Healthcare SA
- BioCina Pty Ltd
- Biofrontera Inc
- Bionova Scientific Inc
- Biogen Inc
- Bristol Myers Squibb (BMS)
- Boehringer Ingelheim
- Bright Path Laboratories Inc
- BSP Pharmaceuticals SpA
- Cambrex Corp
- Can-Fite BioPharma Ltd
- Cardinal Health
- Catalent
- Cellares Corp
- Cellipont Bioservices
- Cerbios Pharma SA
- Chemspec-API Inc
- Chime Biologics Ltd
- Clean Cells SAS
- Cook MyoSite
- Corden Pharma International GmbH
- Curia Global Inc
- Curium
- Dai Nippon Printing Co Ltd
- Daiichi Sankyo
- Delpharm SAS
- Dottikon Exclusive Synthesis AG
- ElevateBio LLC
- Entropy Neurodynamics Ltd
- EOC Pharma Ltd
- Epilepsy GTX
- Esteve Química SA
- EUROAPI
- Evonik Industries AG
- Ferndale Pharma Group Inc
- Flamma SpA
- Freestyle Capital
- Fritz Keller Holding AG
- Fujifilm Diosynth Biotechnologies UK Ltd
- Fujimoto Chemicals Co Ltd
- Gaelic Laboratories
- GBA Holding GmbH
- GeneFab LLC
- Genentech
- Genezen Laboratories Inc
- Genprex Inc
- Gilead Sciences
- GlobalData
- GlaxoSmithKline (GSK)
- HBM Holdings Ltd
- Hovione FarmaCiencia SA
- Huvepharma AD
- Immutep Ltd
- InfoRLife SA
- Ingenza Ltd
- Intertek Group Plc
- Isotope Bidco Ltd
- Isotope Technologies Munich (ITM)
- IVERIC bio Inc
- Janssen
- Jazz Pharmaceuticals Inc
- KC Pharmaceuticals Inc
- Kincell Bio LLC
- Kincellis Advanced Therapies
- Kirin Holdings Co Ltd
- Kyowa Hakko Bio Co Ltd
- Kyowa Pharma Chemical Co Ltd
- Lantheus
- Lannett Co Inc
- Leo Pharma
- Lentigen Technology Inc
- Lifeline Cell Technology LLC
- Eli Lilly and Company
- Lonza Group Ltd
- MacroGenics Inc
- Mabion SA
- MCS Laboratories
- Merck & Co
- Minaris Advanced Therapies LLC
- Moderna
- Monrol
- Neopharmed Gentili SpA
- Niowave
- Northway Biotech UAB
- Northway Group
- Novartis
- Novavax Inc
- Novo
- Nucleis
- Oak HC/FT Partners LLC
- Onyx Scientific Ltd
- Otsuka Pharmaceutical
- Par Sterile Products LLC
- Parabolic Drugs Ltd
- Patheon
- PCI Pharma Services
- PharmaEssentia Corp
- PharmaKorell GmbH
- Pharming Healthcare, Inc
- Pluristyx Inc
- PolyPeptide Group AG
- PPD
- Prime Radiant Fund SLP SICAV-RAIF
- Quoin Pharmaceuticals Ltd
- Raghava Life Sciences Pvt Ltd
- RayzeBio
- Regeneron Pharmaceuticals Inc
- ROVI Pharma Industrial Services
- RPG Active Pharma Ltd
- Samsung Biologics Co Ltd
- Sharp Packaging Services LLC
- SHS Capital
- Siegfried Holding AG
- Simtra US LLC
- SK Bioscience Ltd
- SK Pharmteco Inc
- Skyepharma Production SAS
- Spyre Therapeutics Inc
- Suzhou Hillhouse Qirui Medical Health Industry Investment Partnership
- Swift Ventures Management LLC
- Telix Pharmaceuticals
- TerraPower Isotopes
- Texcell SA
- Thermo Fisher Scientific
- TopChem Pharmaceuticals Ltd
- Uquifa SA
- UniD Manufacturing SA
- Vetter Pharma-Fertigung GmbH & Co KG
- Vifor Pharma UK Ltd
- ViiV Healthcare Company
- Viral Vector Manufacturing Facility Pty Ltd
- Viralgen Vector Core SL
- WuXi AppTec
- WuXi Advanced Therapies
- WuXi Biologics
- WuXi XDC Cayman Inc
- Xiogenix Inc
- Yuhan Chemical Inc
